HealthcareServices

Global Avian Flu Treatment Industry Trends and Market Forecast 2026–2030

February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the avian flu treatment market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Avian Flu Treatment Market show for the 2026–2030 period?

The market for avian flu treatment has experienced robust expansion in recent times. Projections indicate its value will escalate from $13.77 billion in 2025 to $15.04 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 9.3%. Historically, this expansion has been driven by factors such as a rise in avian influenza outbreaks, the adoption of antiviral stockpiling approaches, governmental efforts in disease control, the broadening of hospital-based infectious disease care, and enhanced public health consciousness.

The avian flu treatment market is projected to experience substantial expansion in the coming years. This market is forecast to reach $20.6 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.2%. This anticipated growth is driven by factors such as greater investments in zoonotic disease research, the ongoing development of next-generation vaccines, the expansion of global disease surveillance networks, an increased emphasis on rapid response therapeutics, and enhanced international collaboration for pandemic preparedness. Key trends during this period are anticipated to involve the wider adoption of advanced antiviral therapies, a heightened focus on platforms for rapid vaccine development, the increasing application of monoclonal antibody treatments, the broadening of early diagnosis and surveillance initiatives, and a strengthened commitment to pandemic preparedness.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16352&type=smp

What Drivers Are Shaping The Development Of The Avian Flu Treatment Market?

The expanding recognition and identification of avian flu are anticipated to propel the growth of the avian flu treatment market in the future. Awareness refers to recognizing a condition, while diagnosis involves pinpointing a specific issue based on that recognition. The demand for avian flu treatment is driven by the urgent necessity to safeguard public health, prevent potential pandemics, and protect poultry populations from substantial economic losses. Both awareness and early diagnosis are essential for effective avian flu treatment, enabling swift intervention and containment to prevent its dissemination. For instance, in April 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, stated that more than 8000 people in the US were under active surveillance from February 9, 2022, to March 29, 2024, after encountering animals believed to be infected with the HPAI A (H5N1) virus. Therefore, increasing awareness and diagnosis are contributing to the growth in the avian flu treatment market.

What Segment Types Are Examined In The Avian Flu Treatment Market?

The avian flu treatment market covered in this report is segmented –

1) By Type: Vaccines, Antiviral Agents, Immunoglobulins

2) By Distribution Channel: Online Pharmacies, Offline Pharmacies

3) By End User: Hospital, Institutional Health Centers, Clinics

Subsegments:

1) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Subunit Vaccines, Dna Vaccines, Bivalent And Multivalent Vaccines

2) By Antiviral Agents: Neuraminidase Inhibitors (Oseltamivir, Zanamivir), Polymerase Inhibitors, Antiviral Combination Therapies

3) By Immunoglobulins: Human Immunoglobulin (Ivig), Monoclonal Antibodies, Hyperimmune Serum, Polyvalent Immunoglobulins, Avian Flu-Specific Immunoglobulins

How Are Emerging Trends Affecting The Progression Of The Avian Flu Treatment Market?

Leading companies in the avian flu treatment market are strategically forming alliances to boost the effectiveness and accelerate the creation of new therapies. These partnerships involve joint ventures among pharmaceutical firms, research institutions, and government bodies, designed to combine resources, share expertise, and conduct pioneering clinical trials. For instance, in April 2024, CureVac N.V., a Germany-based biotechnology company, collaborated with GSK plc, a UK-based pharmaceutical company, to develop an investigative influenza A (H5N1) pre-pandemic vaccine candidate. This initiative aims to address the potential future pandemic threat posed by the H5N1 avian influenza virus. The objective of this collaboration is to evaluate the safety, reactogenicity, and immunogenicity of the monovalent vaccine candidate, which encodes an influenza A H5 antigen utilizing CureVac’s proprietary second-generation mRNA backbone. The integrated Phase 1/2 study will assess the vaccine candidate’s safety and efficacy in healthy adults aged 18 to 64, as well as in older adults aged 65 to 85.

Who Are The Top-Performing Companies In The Avian Flu Treatment Market In Recent Years?

Major companies operating in the avian flu treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline Plc, Novartis AG, AstraZeneca Plc, Gilead Sciences Inc., CSL Limited, Moderna Inc., Shionogi & Co. Ltd., Cipla Ltd., Seqirus, Novavax Inc., Sinovac Biotech Ltd., Valneva SE, CureVac AG, BioCryst Pharmaceuticals Inc., Emergent BioSolutions Inc., Dynavax Technologies Corporation, Baxter International Inc., Takeda Pharmaceutical Company Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/avian-flu-treatment-global-market-report

Which Region Currently Holds The Largest Share Of The Avian Flu Treatment Market?

North America was the largest region in the avian flu treatment market in 2025. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the avian flu treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Avian Flu Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16352&type=smp

Browse Through More Reports Similar to the Global Avian Flu Treatment Market 2026, By The Business Research Company

Influenza Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

Influenza Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/influenza-treatment-global-market-report

Swine Flu Vaccination Market Report 2026

https://www.thebusinessresearchcompany.com/report/swine-flu-vaccination-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795